Ad-hoc | 8 September 2005 11:11

aap Implantate AG:Terms of Capital Increase, Guarantee of existing shareholder

Ad hoc correction §15 WpHG Capital Increase aap Implantate AG:Terms of Capital Increase, Guarantee of existing shareholder Ad hoc announcement processed and transmitted by DGAP. The issuer is solely responsible for the content of this announcement. —————————————————————————— Ad hoc correction on behalf of the issuer: Time of publication of the original ad hoc announcement: 7 September 2005, 9.04 p.m. The original ad hoc announcement has been published via the following information distribution systems: Reuters, vwd and Bloomberg In the first paragraph, second sentence, instead of: “This increase of capital stock of up to 1,456,857 shares will be conducted on subscription price of EUR 1.60 with allotment of subscription rights to existing shareholders at a ratio of 21:2.” it must read as follows: “This increase of capital stock of up to 1,460,857 shares will be conducted on subscription price of EUR 1.60 with allotment of subscription rights to existing shareholders at a ratio of 21:2.”. The complete corrected announcement is as follows: Berlin, September 7, 2005 aap Implantate AG: Terms of Capital Increase, Guarantee of existing shareholders The Management and Supervisory Board of aap Implantate AG a German medical technology company specialized in bone fracture healing, joint replacement, bone cements and biomaterials, today decided the already announced capital increase. This increase of capital stock of up to 1,460,857 shares will be conducted on subscription price of EUR 1.60 with allotment of subscription rights to existing shareholders at a ratio of 21:2. There will be no trading in subscription rights and the new stocks will be entitled to a share in profits from January 1, 2005. The capital increase is completely guaranteed by existing shareholders of aap, so that all not acquired shares will be subscribed by this group of investors, which also includes members of the management and supervisory board. But the management and supervisory board reserved to themselves also to allocate not acquired shares to third parties (institutional investors or employees). From the capital increase the company will receive up to EUR 2.3 million before transaction costs. The proceeds are intended to be used for financing an acquisition in the biomaterials segment and to continue to step up its operative business. aap Implantate AG Lorenzweg 5 12099 Berlin Deutschland ISIN: DE0005066609 WKN: 506660 Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, Hamburg, Hannover, München und Stuttgart End of ad hoc announcement (c)DGAP 08.09.2005 081111 Sep 05